With the exception of the TIC-initiated tumor derived from one non-SPARC transfected cell line, the other 3 TIC-derived tumors all had a similar level of focal expression of the SPARC protein, showing moderate immunoreactivity in approximately 10% of the tumor. Here, SPARC is linked to neoplasm.